Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Formulary Structure topic
No spam. Unsubscribe anytime.
Formulary subcommittee considers switching to exclusionary list and adopting 2025 AHFS by reference
Summary
At a Formulary Subcommittee meeting, members discussed changing the naturopathic formulary from an inclusion list to an exclusionary list and incorporating the 2025 AHFS classification by reference, citing the Oregon model and a legislative request for pharmacy consultation.
The Formulary Subcommittee of the Maine Board of Complementary Health Care Providers discussed a proposed structural change to the Board's formulary, including converting the current inclusion list to an exclusionary list and incorporating the 2025 AHFS classification by reference. Chair Sarah Ackerly provided historical context for Public Law 2025, Chapter 150 and noted a legislative committee request that the Board consult pharmacist members of the Maine Board of Pharmacy on any formulary revisions.
Subcommittee members identified the Oregon formulary as an example and discussed implications of by-reference adoption of AHFS. The conversation emphasized that an exclusionary format would list only prohibited items while relying on the AHFS classification for the remainder of the formulary's scope. The proposal remains at the discussion stage and would require drafting rule language and consultation with pharmacy stakeholders before any formal rule-making action.
